Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes
- Status
- TERMINATED
- Phase
- PHASE4
Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year
- Status
- COMPLETED
- Phase
- PHASE3
Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)
- Status
- COMPLETED
- Phase
- PHASE1
A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica
- Status
- TERMINATED
- Phase
- PHASE2
Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
- Status
- COMPLETED
- Phase
- N/A
Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients
- Status
- COMPLETED
- Phase
- PHASE2
Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE2